ARALEZ PHARMACEUTICALS INC. Operating Income
ARALEZ PHARMACEUTICALS INC. reported Operating Income of -$14.07 million for the 3-month period ending 2018-03-31, per its 10-Q filed 2018-05-08.
Discontinued › Income Statement
us-gaap:OperatingIncomeLoss · last filed 2018-05-08
- ARALEZ PHARMACEUTICALS INC. operating income (loss) for the quarter ending 2018-03-31 was -$14.07M.
- ARALEZ PHARMACEUTICALS INC. operating income (loss) for the quarter ending 2017-12-31 was -$37.96M.
- ARALEZ PHARMACEUTICALS INC. operating income (loss) for the quarter ending 2017-09-30 was -$17.44M.
- ARALEZ PHARMACEUTICALS INC. operating income (loss) for the quarter ending 2017-06-30 was -$20.42M.
- ARALEZ PHARMACEUTICALS INC. operating income (loss) for fiscal 2017 was -$96.50M.
- ARALEZ PHARMACEUTICALS INC. operating income (loss) for fiscal 2016 was -$102.58M.
- ARALEZ PHARMACEUTICALS INC. operating income (loss) for fiscal 2015 was -$37.47M, a 326.03% decline from fiscal 2014.
- ARALEZ PHARMACEUTICALS INC. operating income (loss) for fiscal 2014 was $16.58M.
| Period end | Operating Income (Loss) 3 month | Operating Income (Loss) 6 month | Operating Income (Loss) 9 month | Operating Income (Loss) 12 month |
|---|---|---|---|---|
| 2018-03-31 | -$14.07M 10-Q · filed 2018-05-08 | -$52.03M derived: sum of 2 quarters · filed 2018-05-08 | -$69.47M derived: sum of 3 quarters · filed 2018-05-08 | -$89.89M derived: sum of 4 quarters · filed 2018-05-08 |
| 2017-12-31 | -$37.96M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-14 | -$55.40M derived: sum of 2 quarters · filed 2018-03-14 | -$75.82M derived: sum of 3 quarters · filed 2018-03-14 | -$96.50M 10-K · filed 2018-03-14 |
| 2017-09-30 | -$17.44M 10-Q · filed 2017-11-09 | -$37.86M derived: sum of 2 quarters · filed 2017-11-09 | -$58.54M 10-Q · filed 2017-11-09 | -$86.75M derived: sum of 4 quarters · filed 2018-05-08 |
| 2017-06-30 | -$20.42M 10-Q · filed 2017-08-09 | -$41.10M 10-Q · filed 2017-08-09 | -$69.31M derived: sum of 3 quarters · filed 2018-05-08 | -$88.94M derived: sum of 4 quarters · filed 2018-05-08 |
| 2017-03-31 | -$20.68M 10-Q · filed 2018-05-08 | -$48.89M derived: sum of 2 quarters · filed 2018-05-08 | -$68.52M derived: sum of 3 quarters · filed 2018-05-08 | -$85.64M derived: sum of 4 quarters · filed 2018-05-08 |
| 2016-12-31 | -$28.20M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-14 | -$47.84M derived: sum of 2 quarters · filed 2018-03-14 | -$64.96M derived: sum of 3 quarters · filed 2018-03-14 | -$102.58M 10-K · filed 2018-03-14 |
| 2016-09-30 | -$19.63M 10-Q · filed 2017-11-09 | -$36.76M derived: sum of 2 quarters · filed 2017-11-09 | -$74.38M 10-Q · filed 2017-11-09 | -$88.52M derived: sum of 4 quarters · filed 2018-03-14 |
| 2016-06-30 | -$17.12M 10-Q · filed 2017-08-09 | -$54.74M 10-Q · filed 2017-08-09 | -$68.88M derived: sum of 3 quarters · filed 2018-03-14 | -$77.08M derived: sum of 4 quarters · filed 2018-03-14 |
| 2016-03-31 | -$37.62M 10-Q · filed 2017-05-09 | -$51.76M derived: sum of 2 quarters · filed 2018-03-14 | -$59.95M derived: sum of 3 quarters · filed 2018-03-14 | -$75.25M derived: sum of 4 quarters · filed 2018-03-14 |
| 2015-12-31 | -$14.14M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-14 | -$22.33M derived: sum of 2 quarters · filed 2018-03-14 | -$37.62M derived: sum of 3 quarters · filed 2018-03-14 | -$37.47M 10-K · filed 2018-03-14 |
| 2015-09-30 | -$8.19M 10-Q · filed 2016-11-08 | -$23.49M derived: sum of 2 quarters · filed 2016-11-08 | -$23.33M 10-Q · filed 2016-11-08 | |
| 2015-06-30 | -$15.29M 10-Q · filed 2016-08-09 | -$15.14M 10-Q · filed 2016-08-09 | ||
| 2015-03-31 | $158.00K 10-Q · filed 2016-05-10 | |||
| 2014-12-31 | $16.58M 10-K · filed 2017-03-13 |